Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watch
Divi's Laboratories set out an expansion in a quarterly results development.
· Economic Times Markets, ET Stocks
India's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabilities. Jefferies emphasizes the critical role of specialized manufacturing skills and a strong project pipeline for achieving success. With Divi's Laboratories and Sai Life Sciences excelling in these domains, there is potential for notable earnings growth.
The analysis
Against that, the stock is +1.2% on the day at ₹9,780.00, and has returned +24.8% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved -0.9% over the same period, so Divi's Laboratories is running 25.7 points ahead of its peers.
For Divi's Laboratories, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Divi's Laboratories (DIVISLAB), in Pharma & Healthcare.
- On the day, 2 of 2 are higher: Sai Life Sciences leads at +4.1% and Divi's Laboratories trails at +1.2%.
- Over three months: Divi's Laboratories +24.8% against Pharma & Healthcare -0.9% (25.7 points ahead); Sai Life Sciences +18.4% against Pharma & Healthcare -0.9% (19.3 points ahead).
- Trading well above normal today: Sai Life Sciences at 2.8 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Divi's LaboratoriesDIVISLAB · Pharma & Healthcare | ₹9,780.00 | +1.2% | +5.3% | +24.8% | 0.0% | 1.8× | — |
| Sai Life SciencesSAILIFE · Pharma & Healthcare | ₹1,557.50 | +4.1% | +2.2% | +18.4% | -7.0% | 2.8× | — |
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Divi's Laboratories, Sai Life Sciences
Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Sun Pharma Q2 profit falls 36% as litigation costs hit earnings
Max Healthcare Q2 net profit falls 15.6% on higher operating, tax expenses
Max Healthcare Q2 PAT rises 10% to ₹448 cr on higher bed occupancy
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY